Youngy Health Co Ltd (300247) — Strategic Asset Allocation Index
Youngy Health Co Ltd (300247) has a Strategic Asset Allocation Index of 22.0% as of June 2023. Strategic assets (PP&E of CN¥235.19 Million plus long-term investments of CN¥-) total CN¥235.19 Million, measured against net assets of CN¥1.07 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Youngy Health Co Ltd's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Youngy Health Co Ltd Strategic Asset Allocation Index (2008–2022)
This chart shows how Youngy Health Co Ltd's Strategic Asset Allocation Index has evolved across 15 annual periods from 2008 to 2022. As of June 2023, the index stands at 22.0%, representing strategic assets of CN¥235.19 Million against net assets of CN¥1.07 Billion CNY. For live market cap and overall valuation, see Youngy Health Co Ltd market capitalisation.
Annual Strategic Asset Allocation Index for Youngy Health Co Ltd (2008–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Youngy Health Co Ltd from 2008 to 2022, covering 15 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See shareholders equity of Youngy Health Co Ltd for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 23.9% | CN¥246.08 Million | CN¥246.08 Million | CN¥- | CN¥1.03 Billion | ▼ -6.2 pp |
| 2021 | 30.1% | CN¥259.44 Million | CN¥259.44 Million | CN¥- | CN¥861.11 Million | ▲ +1.8 pp |
| 2020 | 28.4% | CN¥235.89 Million | CN¥235.89 Million | CN¥- | CN¥831.31 Million | ▼ -0.7 pp |
| 2019 | 29.1% | CN¥258.88 Million | CN¥258.88 Million | CN¥- | CN¥890.52 Million | ▼ -8.7 pp |
| 2018 | 37.8% | CN¥604.60 Million | CN¥275.83 Million | CN¥328.77 Million | CN¥1.60 Billion | ▲ +12.5 pp |
| 2017 | 25.2% | CN¥594.90 Million | CN¥283.59 Million | CN¥311.31 Million | CN¥2.36 Billion | ▲ +4.4 pp |
| 2016 | 20.9% | CN¥473.67 Million | CN¥298.27 Million | CN¥175.40 Million | CN¥2.27 Billion | ▼ -9.5 pp |
| 2015 | 30.4% | CN¥428.24 Million | CN¥293.10 Million | CN¥135.14 Million | CN¥1.41 Billion | ▼ -8.8 pp |
| 2014 | 39.2% | CN¥265.01 Million | CN¥265.01 Million | CN¥- | CN¥675.89 Million | ▼ -12.3 pp |
| 2013 | 51.5% | CN¥302.06 Million | CN¥302.06 Million | CN¥- | CN¥586.22 Million | ▲ +5.4 pp |
| 2012 | 46.1% | CN¥262.47 Million | CN¥262.47 Million | CN¥- | CN¥568.73 Million | ▲ +17.0 pp |
| 2011 | 29.1% | CN¥166.12 Million | CN¥166.12 Million | CN¥- | CN¥570.81 Million | ▼ -22.6 pp |
| 2010 | 51.7% | CN¥117.98 Million | CN¥117.98 Million | CN¥- | CN¥227.98 Million | ▲ +29.9 pp |
| 2009 | 21.8% | CN¥33.29 Million | CN¥33.29 Million | CN¥- | CN¥152.57 Million | ▲ +5.2 pp |
| 2008 | 16.6% | CN¥19.47 Million | CN¥19.47 Million | CN¥- | CN¥116.96 Million | — |